Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
暂无分享,去创建一个
J. Leipsic | M. Mack | N. Weissman | E. Tuzcu | L. Svensson | J. Moses | M. Leon | D. C. Miller | S. Kapadia | P. Pibarot | J. Webb | B. Whisenant | R. Smalling | R. D'Agostino | Craig R. Smith | H. Herrmann | D. Cohen | V. Thourani | D. Kereiakes | G. Ailawadi | M. Alu | R. Makkar | V. Babaliaros | S. Kodali | R. Suri | W. Szeto | R. Hahn | Mathew R. Williams | K. Greason | W. Jaber | Scott D. Lim | S. Malaisrie | R. Parvataneni | C. Devireddy | R. Makkar | R. D'Agostino | M. Mack | Maria C. Alu | D. C. Miller | D. Cohen | Jeffrey W. Moses | Martin B. Leon | Howard C Herrmann | D. Cohen | D. C. Miller | Craig R. Smith | Neil J. Weissman | Lars G. Svensson | Wael A. Jaber | Michael J. Mack | Howard C. Herrmann | John G. Webb | David J. Cohen | Ralph B D'Agostino | Scott Lim | Ralph D'Agostino
[1] J. Leipsic,et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. , 2016, European heart journal.
[2] J. Carroll,et al. Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. , 2016, The Annals of thoracic surgery.
[3] M. Mack,et al. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery. , 2015, JACC. Cardiovascular interventions.
[4] I. Meredith,et al. Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System. , 2015, JACC. Cardiovascular interventions.
[5] F. Santini,et al. 1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study. , 2015, Journal of the American College of Cardiology.
[6] M. Mack,et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.
[7] M. Mack,et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.
[8] M. Mack,et al. Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy , 2015, Circulation.
[9] L. W. Andersen,et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.
[10] Philippe Pibarot,et al. Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. , 2015, JACC. Cardiovascular imaging.
[11] M. Mack,et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. , 2015, European heart journal.
[12] Sean M. O'Brien,et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. , 2015, The Annals of thoracic surgery.
[13] R. Lange,et al. The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[14] Nancy M Albert,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.
[15] Thoralf M Sundt,et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[16] E. Tuzcu,et al. Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. , 2014, Journal of the American College of Cardiology.
[17] J. Coselli,et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. , 2014, Journal of the American College of Cardiology.
[18] Maurice Buchbinder,et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.
[19] Susheel Kodali,et al. Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement , 2013 .
[20] P. Jüni,et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. , 2013, European heart journal.
[21] Robert H. Anderson,et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. , 2013, JACC. Cardiovascular interventions.
[22] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.
[23] O. Alfieri,et al. Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. , 2012, American heart journal.
[24] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[25] Alec Vahanian. Valvular Heart Disease 2007 , 2012 .
[26] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[27] A. D. Cunningham,et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. , 2011, Journal of the American College of Cardiology.
[28] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[29] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[30] R. D'Agostino. Propensity Scores in Cardiovascular Research , 2007, Circulation.
[31] Helmut Baumgartner,et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .
[32] R. D'Agostino. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. , 2005, Statistics in medicine.